Eszopiclone set for Japanese filing following positive local data
This article was originally published in Scrip
Executive Summary
Eisai is planning a Japanese approval filing for the insomnia product eszopiclone in the current fiscal year ending 31 March 2011 following positive results from two local clinical trials.